INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Vistagen Therapeutics, Inc. (VTGN) ...
Eagletribune
A class action lawsuit has been filed against Vistagen Therapeutics alleging false and misleading statements regarding their Phase 3 trial.Summary
A shareholder class action lawsuit has been filed against Vistagen Therapeutics, Inc. (NASDAQ: VTGN). The suit claims the company issued false or misleading statements and failed to disclose critical risks associated with its Phase 3 PALISADE-3 trial of fasedienol. Investors who purchased Vistagen shares between April 1, 2024, and December 16, 2025, and suffered a significant loss are encouraged to contact Corey D. Holzer, Esq. at [email protected] or call (888) 508-6832 for information about their legal rights. Further details are available at www.holzerlaw.com/case/vistagen-therapeutics/.
(Source：Eagletribune)